By
Adrianne Appel2025-08-04T18:13:00
The chief executive and medical director of Fast Lab Technologies allegedly engaged in a $500 million fraud scheme involving COVID-19 tests, the U.S. Department of Justice (DOJ) said.
Fast Lab CEO Cemhan “Jimmy” Biricik and medical director, Martin Perlin, M.D., created the business and its website in 2021, during the height of the pandemic, and advertised “free” COVID-19 tests.
Fast Lab, based in New York, collected individuals’ insurance information and used it to fraudulently bill private insurers and federal health programs, including Medicare, Medicaid, and TRICARE, for COVID-19 testing that never took place, the DOJ alleged.
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2025-11-19T14:10:00Z By Adrianne Appel
Horizon Blue Cross Blue Shield of New Jersey has agreed to pay $100 million to settle allegations that its 2020 contract with the state was fraudulent, according the state’s Attorney General.
2025-10-03T21:24:00Z By Adrianne Appel
While the Trump administration may have shifted away from pursuing small, white-collar, financial crimes, its focus on health care fraud cases is as hot as ever.
2025-09-05T21:03:00Z By Aly McDevitt
Nestlé dismissed its CEO over an undisclosed relationship with a subordinate, a clear breach of the company’s code of business conduct. The dismissal underscores that no one is exempt from compliance obligations, even top leadership.
2026-02-05T00:55:00Z By Ruth Prickett
Major accountancy firms in France are under investigation for anti-competitive practices. The French competition watchdog embarked on a series of “unannounced inspections” and removed documents relating to audit and reporting on Jan. 13.
2026-02-03T23:22:00Z By Neil Hodge
The European Commission has launched a formal investigation against Elon Musk’s X under the Digital Services Act over fears that its AI tool Grok may be producing and disseminating illegal material.
2026-02-03T22:57:00Z By Adrianne Appel
Three former executives at Archer-Daniels-Midland intentionally misled investors by inflating the performance of the company’s Nutrition unit, the U.S. Securities and Exchange Commission has alleged.
Site powered by Webvision Cloud